A World Health Organization (WHO) panel on Wednesday backed the use of molnupiravir- Merck & Co's COVID-19 antiviral pill- for high-risk patients.
The expert panel...
China's medical products regulator said on Saturday it has given conditional approval for Pfizer's COVID-19 drug Paxlovid, making it the first oral pill specifically...
Japanese Prime Minister Fumio Kishida said on Monday the government would consider granting conditional early approval for the oral COVID-19 treatment being developed by...
UK scientists will begin testing Merck and Ridgeback Biotherapeutics' antiviral pill molnupiravir as a possible treatment for patients hospitalised with COVID-19, amid the worldwide...
A UN-backed agency has struck a deal for nearly 30 generic drugmakers to make low-cost versions of Merck's COVID-19 pill molnupiravir for poorer nations,...
Pfizer said Tuesday that clinical trials confirmed its Covid pill, a new type of antiviral treatment that should withstand the mutations seen with Omicron,...